Genetic Deletion of GABA Receptors Reveals Distinct Requirements of Neurotransmitter Receptors for GABAergic and Glutamatergic Synapse Development.

Front Cell Neurosci

Synapse and Neural Circuit Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.

Published: June 2019

AI Article Synopsis

  • GABA receptors (GABARs) are important for both inhibitory balance in the adult brain and neuronal development in the immature brain.
  • Using CRISPR-CAS9 technology, researchers eliminated GABARs in single hippocampal neurons, finding that GABAergic synapses rely heavily on GABARs, while glutamatergic synapses do not.
  • The study highlighted that inhibitory synapse formation is dependent on GABARs, while excitatory synapses have different molecular mechanisms for their development.

Article Abstract

In the adult brain GABA receptors (GABARs) mediate the majority of synaptic inhibition that provides inhibitory balance to excitatory drive and controls neuronal output. In the immature brain GABAR signaling is critical for neuronal development. However, the cell-autonomous role of GABARs in synapse development remains largely unknown. We have employed the CRISPR-CAS9 technology to genetically eliminate GABARs in individual hippocampal neurons and examined GABAergic and glutamatergic synapses. We found that development of GABAergic synapses, but not glutamatergic synapses, critically depends on GABARs. By combining different genetic approaches, we have also removed GABARs and two ionotropic glutamate receptors, AMPA receptors (AMPARs) and NMDA receptors (NMDARs), in single neurons and discovered a striking dichotomy. Indeed, while development of glutamatergic synapses and spines does not require signaling mediated by these receptors, inhibitory synapse formation is crucially dependent on them. Our data reveal a critical cell-autonomous role of GABARs in inhibitory synaptogenesis and demonstrate distinct molecular mechanisms for development of inhibitory and excitatory synapses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558517PMC
http://dx.doi.org/10.3389/fncel.2019.00217DOI Listing

Publication Analysis

Top Keywords

glutamatergic synapses
12
gaba receptors
8
gabaergic glutamatergic
8
synapse development
8
cell-autonomous role
8
role gabars
8
receptors
7
development
6
gabars
6
synapses
5

Similar Publications

A unique pool of immature glutamatergic neurons in the primate amygdala, known as the paralaminar nucleus (PL), are maturing between infancy and adolescence. The PL is a potential substrate for the steep growth curve of amygdala volume during this developmental period. A microglial component is also embedded among the PL neurons, and likely supports local neuronal maturation and emerging synaptogenesis.

View Article and Find Full Text PDF

Background: Argonaute2 (Ago2) plays an essential role in RISC-mediated silencing of target mRNAs, which are critical for cellular functions. Argonaute2 Syndrome, also known as Ago2 Syndrome, is a rare neurological disorder recently discovered in humans. It has significant implications for brain development, yet it remains unstudied to date METHOD: To study this effect, we deleted the Ago2 gene in GABAergic (Slc32a1 cre) and Glutamatergic (Slc17a6 cre) mice.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Yale University, New Haven, CT, USA.

Background: Advances in Alzheimer's disease (AD) have revealed a novel fluid biomarker, tau phosphorylated at T217 (pT217-tau), in CSF and plasma, that predicts AD prior to cognitive deficits. Understanding the role of pT217-tau is important in assessing efficacy of novel treatments aimed at early-stage disease. However, it is unknown why pT217-tau is effective in predicting brain pathology, as little is known about early, soluble pT217-tau brain expression.

View Article and Find Full Text PDF

Background: Kv1.3 channels are promising therapeutic targets to modulate neuroinflammatory responses in neurodegenerative disease including Alzheimer's disease (AD). Although the ability of Kv1.

View Article and Find Full Text PDF

VNS paired with training enhances recognition memory: mechanistic insights from proteomic analysis of the hippocampal synapse.

Front Mol Neurosci

December 2024

Cognitive Neuroscience, 711th Human Performance Wing, Air Force Research Laboratory, Wright-Patterson AFB, OH, United States.

Introduction: Recognition memory, an essential component of cognitive health, can suffer from biological limitations of stress, aging, or neurodegenerative disease. Vagus nerve stimulation (VNS) is a neuromodulation therapy with the potential to improve cognitive function. This study investigated the effectiveness of multiple sessions of VNS to enhance recognition memory in healthy rodents and the underlying cognitive benefits of VNS by proteomic analysis of the synaptosome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!